| PERIOD ENDING | 4-Jan-09 | 30-Dec-07 | 31-Dec-06 | | Total Revenue | 295,329 | 319,264 | 251,587 | | Cost of Revenue | 235,333 | 254,060 | 200,734 | | | Gross Profit | 59,996 | 65,204 | 50,853 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 44,005 | 42,792 | 34,296 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 15,991 | 22,412 | 16,557 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,865 | 4,175 | 3,423 | | Earnings Before Interest And Taxes | 17,856 | 26,587 | 19,980 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 17,856 | 26,587 | 19,980 | | Income Tax Expense | 6,226 | 9,128 | 6,916 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 11,630 | 17,459 | 13,064 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 11,630 | 17,459 | 13,064 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,630 | $17,459 | $13,064 |
|
0.49% Nasdaq 0.00%
Income Statement
